OCTAVIA YANCEY: Open Payments
NPI 1891554846 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$589 in 16 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $254 · 2025 $589
Food & beverage: $505Education: $84
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 6 | $279 |
| Janssen Biotech, Inc. | 3 | $185 |
| ABBVIE INC. | 2 | $37 |
| PFIZER INC. | 2 | $32 |
| GENZYME CORPORATION | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
Products named: REZDIFFRA, TREMFYA, DUPIXENT, VOQUEZNA, SKYRIZI, RINVOQ, VELSIPITY, XELJANZ.
Industry payments across MD — which companies pay providers there.
